We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMTPH.L Regulatory News (MTPH)

  • There is currently no data for MTPH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Form 8.3 - Midatech Pharma PLC

3 Jul 2020 07:00

 

FORM 8.3

PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

Rule 8.3 of the Takeover Code (the “Code”)

1. KEY INFORMATION

(a) Full name of discloser:

Intracoastal Capital LLC

(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named.

 

(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

Midatech Pharma Plc

(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree:

 

(e) Date position held/dealing undertaken:

For an opening position disclosure, state the latest practicable date prior to the disclosure

18/May/20

(f) In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

If it is a cash offer or possible cash offer, state “N/A”

YES / NO / N/A

If YES, specify which:N/A

2. POSITIONS OF THE PERSON MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a) Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates following the dealing (if any)

Class of relevant security:

 

 

 

 

Interests

Short positions

 

Number

%

Number

%

(1) Relevant securities owned and/or controlled:

 

 

 

 

(2) Cash-settled derivatives:

 

 

 

 

 

(3) Stock-settled derivatives (including options) and agreements to purchase/sell:

 

 

 

 

 

TOTAL:

 

 

 

 

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

(b) Rights to subscribe for new securities (including directors’ and other employee options)

Class of relevant security in relation to which subscription right exists:

Warrant to purchase ADR’s

Details, including nature of the rights concerned and relevant percentages:

238,392 Warrants with a strike price of USD$2.05 for an equivalent number of ADR’s

3. DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 3(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

The currency of all prices and other monetary amounts should be stated.

(a) Purchases and sales

Class of relevant security

Purchase/sale

 

Number of securities

Price per unit

ADR’s ISIN -US59564R3021

Sale

 

238,392

$1.57USD

(b) Cash-settled derivative transactions

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

 

 

 

(c) Stock-settled derivative transactions (including options)

(i) Writing, selling, purchasing or varying

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

 

 

 

 

 

 

 

(ii) Exercise

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

 

 

 

(d) Other dealings (including subscribing for new securities)

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

ADR’s ISIN -US59564302

Receipt of Placement of ADR’s

238,392

$1.65USD

4. OTHER INFORMATION

(a) Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the person making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state “none”

 

 

none

(b) Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the person making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state “none”

 

 

none

(c) Attachments

Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

6/25/20

Contact name:

Mitchell Kopin

Telephone number*:

847-562-9030

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel’s Market Surveillance Unit is available for consultation in relation to the Code’s disclosure requirements on +44 (0)20 7638 0129.

*If the discloser is a natural person, a telephone number does not need to be included, provided contact information has been provided to the Panel’s Market Surveillance Unit.

The Code can be viewed on the Panel’s website at www.thetakeoverpanel.org.uk.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200702005540/en/

Copyright Business Wire 2020

Date   Source Headline
5th Dec 20192:00 pmRNSEuro 2.6m Grant for clinical development of MTX110
5th Dec 20197:00 amRNSHolding(s) in Company
4th Nov 20195:41 pmRNSHolding(s) in Company
31st Oct 20196:12 pmRNSHolding(s) in Company
31st Oct 20199:26 amRNSHolding(s) in Company
28th Oct 20197:01 amRNSTotal Voting Rights
28th Oct 20197:00 amRNSClosing of US$3.0m Registered Direct Offering
24th Oct 20197:00 amRNSMTX110 Receives Orphan Designation for DIPG
23rd Oct 20197:08 amRNSUS$3.0m Registered Direct Offering
17th Oct 20192:23 pmRNSHolding(s) in Company
15th Oct 20192:59 pmRNSHolding(s) in Company
8th Oct 20197:00 amRNSCommencement of MTD201 Phase 1 Study
7th Oct 20197:00 amRNSPDMR Dealing
7th Oct 20197:00 amRNSIssue of Equity for Employee Share Incentive Plan
4th Oct 20197:00 amRNSPDMR Dealing
3rd Oct 20197:00 amRNSPDMR Dealing
2nd Oct 201910:19 amRNSAward of Options to a Director
2nd Oct 20197:00 amRNSPDMR Dealing
30th Sep 20197:13 amRNSInterim Results
24th Sep 20197:00 amRNSFiling of U.S. Shelf Registration
20th Sep 20197:00 amRNSMTD201 Phase 1 Study Approval
11th Sep 201910:05 amRNSReceipt of Spanish Government Loan
9th Sep 20197:00 amRNSDirectorate Change
31st Jul 20197:00 amRNSAppointment of Non-Executive Director
19th Jul 20194:40 pmRNSSecond Price Monitoring Extn
19th Jul 20194:35 pmRNSPrice Monitoring Extension
19th Jul 20197:00 amRNSMTX102 Safety Results
3rd Jul 20199:30 amRNSMTX110 Update
19th Jun 201912:00 pmRNSResult of AGM
13th Jun 20197:00 amRNSMTD201 Development Plan
24th May 20195:25 pmRNSPosting of Annual Report & Notice of AGM
7th May 20197:00 amRNSTurner Pope Investor Evening
26th Apr 20194:30 pmRNSReceipt of NASDAQ Notification
25th Apr 20194:40 pmRNSSecond Price Monitoring Extn
25th Apr 20194:35 pmRNSPrice Monitoring Extension
24th Apr 20194:40 pmRNSSecond Price Monitoring Extn
24th Apr 20194:35 pmRNSPrice Monitoring Extension
24th Apr 20192:05 pmRNSSecond Price Monitoring Extn
24th Apr 20192:00 pmRNSPrice Monitoring Extension
24th Apr 20197:00 amRNSFinal Results
5th Apr 201911:05 amRNSSecond Price Monitoring Extn
5th Apr 201911:00 amRNSPrice Monitoring Extension
29th Mar 20192:06 pmRNSSecond Price Monitoring Extn
29th Mar 20192:00 pmRNSPrice Monitoring Extension
29th Mar 20197:00 amRNSSpanish Government Loan Approval
20th Mar 20197:00 amRNSADR Ratio Change
28th Feb 20194:41 pmRNSSecond Price Monitoring Extn
28th Feb 20194:36 pmRNSPrice Monitoring Extension
28th Feb 201911:05 amRNSSecond Price Monitoring Extn
28th Feb 201911:00 amRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.